Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-15

FDA Approved: CEFPROZIL — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cefprozil submitted by Rising Pharma Holdings, Inc., resulting in an updated labeling for the product. This reflects…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefprozil (cefprozil)

Snippet

SUPPL AP for CEFPROZIL (CEFPROZIL)